MARIA LASERNA: Open Payments
NPI 1649412420 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,570 in 302 payments from 24 companies in 2025. Trend: 2023 $3,197 · 2024 $3,338 · 2025 $5,570
Food & beverage: $5,297Education: $273
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 33 | $807 |
| Incyte Corporation | 31 | $737 |
| Janssen Biotech, Inc. | 36 | $633 |
| ABBVIE INC. | 25 | $416 |
| GENZYME CORPORATION | 9 | $299 |
| Arcutis Biotherapeutics, Inc. | 36 | $297 |
| PFIZER INC. | 17 | $267 |
| Galderma Laboratories, L.P. | 15 | $242 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $237 |
| LEO Pharma Inc. | 18 | $233 |
Products named: Bimzelx, OPZELURA, TREMFYA, DUPIXENT, Zoryve, SKYRIZI, CIBINQO, SPEVIGO.
Industry payments across MD — which companies pay providers there.
